Learning from the ebola success: can a MAB also save lives after yellow fever infection?

Ended Project Grant Awarded Last action

Award ID
R42AI155275
Recipient
Awarding agency
Obligated
$7,242,001

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $6,242,591.00 Federal
  • $999,410.00 Non-federal
Place of performance
Washington, DC 20052, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $978,679 $0
Amendment $988,498 $0
Amendment $988,498 $0
Amendment $988,498 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$37,519 $0
Amendment $37,519 $0
Amendment -$37,519 -$37,519
Amendment $37,519 $37,519
Amendment $999,410 $0
Amendment $999,410 $999,410
Original award $299,598 $0
Show all 14

Quick answers

Who received award R42AI155275?

R42AI155275 was awarded to Mabloc, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 2, 2020.

How much is award R42AI155275 worth?

$7,242,001 has been obligated on R42AI155275: $6,242,591 in federal funding and $999,410 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award